Alexander Schmitz

Alexander Schmitz joined Endeavour Vision in 2015, where he serves as senior investment director, investing in medical technology and digital health investments across multiple therapeutic areas.

Alex brings more than two decades of business and strategy experience in both medical device and high-technology companies. In addition to Relievant, he currently represents Endeavour Vision on the boards of EndoStim, VentureMed, and VertiFlex, and serves as a board observer at Gynesonics. He is a member of the steering committee for PCR Innovators’ Day and serves as both a jury member and expert panelist for the Healthtech Summit.

Prior to joining the Endeavour Vision team, Alex spent nine years with Biosensors International Group, an interventional cardiology company, where he served as vice president of business development. He previously worked with LogiSpring Ventures, MicroStrategy and McKinsey & Co.

Alex holds an MBA from INSEAD and a BSFS, magna cum laude, from Georgetown University.